Viscocanalostomy versus trabeculectomy in patients with bilateral high-tension glaucoma

Int Ophthalmol. 2004 Jul;25(4):207-13. doi: 10.1007/s10792-004-6741-7. Epub 2005 Sep 29.

Abstract

Results of trabeculectomy (TE) and viscocanalostomy (VCO) were compared in a prospective randomised study in two fellow eyes of 22 consecutive patients with bilateral symmetrical high-tension glaucoma. Rates of overall surgical success with intraocular pressures (IOP) < or = 18 mm Hg with or without medications were 91 for the TE, and 95 for the VCO group after a mean follow-up of 18 months. Complete success rates without medications were 64 and 59 for TE and VCO groups, respectively (p = 0.750). Both procedures significantly reduced IOP, however, IOP course following trabeculectomy was significantly lower (p = 0.026). Rates of complications were not found to be different between the two groups of eyes, except for an apparent--though not significant (p = 0.066)--increase in cataract progression with TE. Various types of conjunctival blebs were detected in all eyes with surgical success in both groups, however, diffuse, elevated or multi-cystic functional blebs appeared to be more predominant in eyes with TE, compared to the VCO group in which low-lying, localised blebs had a higher incidence (p = 0.015). Viscocanalostomy was found to be a safe and effective filtration technique in patients with uncomplicated high-tension glaucoma, though IOP decrease was more pronounced with trabeculectomy.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Aged
  • Blister / epidemiology
  • Blister / etiology
  • Cataract / physiopathology
  • Conjunctival Diseases / epidemiology
  • Conjunctival Diseases / etiology
  • Disease Progression
  • Female
  • Filtering Surgery / adverse effects
  • Filtering Surgery / methods*
  • Glaucoma / physiopathology*
  • Glaucoma / surgery*
  • Humans
  • Incidence
  • Intraocular Pressure*
  • Male
  • Middle Aged
  • Postoperative Period
  • Sclera / surgery*
  • Trabeculectomy* / adverse effects
  • Treatment Outcome